Pfizer (NYSE: PFE) and its German partner BioNTech indicated that their Coronavirus vaccine, dubbed BNT162b2, was over 90% effective at preventing Covid-19 infections among volunteers, based on early data from phase 3 trials...
[Motley Fool] Is It Too Late to Buy Pfizer Stock? .Pfizer raised its forecast for coronavirus vaccine revenue this year. · But Pfizer also noted that some forecasts for vaccine sales next year look high. · Still, ... View more
[CNN] Pfizer shares soar on positive test results for Covid pill - CNN .Shares of drug giant Pfizer surged nearly 10% Friday after the company announced positive test results for an experimental pill it has developed to fight ... View more
[Barron's] Pfizer Stock Soars as Covid-19 Antiviral Shows Stunning Efficacy .Shares of Pfizer (ticker: PFE) jumped 12.2% in premarket trading Friday, while Merck (MRK) shares dropped 8.6%. ... View more
[Fox Business] Pfizer stock jumps, Moderna, Merck tumble .Pfizer's stock soars after it delivers groundbreaking results for its COVID-19 oral antiviral candidate, PAXLOVID. ... View more